Search Results - "Lutterotti, A."

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review by Stathopoulos, P., Léger, K., Foege, M., Lutterotti, A., Müller, A., Schanz, U., Jelcic, I., Martin, R.

Get full text

Olfactory threshold is impaired in early, active multiple sclerosis by Lutterotti, A, Vedovello, M, Reindl, M, Ehling, R, DiPauli, F, Kuenz, B, Gneiss, C, Deisenhammer, F, Berger, T

“…Background: Olfactory dysfunction has been reported in multiple sclerosis (MS). However, to date no data are available on different qualities of olfactory…”
Get full text

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis by Di Pauli, F, Reindl, M, Ehling, R, Schautzer, F, Gneiss, C, Lutterotti, A, O’Reilly, EJ, Munger, KL, Deisenhammer, F, Ascherio, A, Berger, T

“…Background Cigarette smoking increases the risk for development of multiple sclerosis and modifies the clinical course of the disease. In this study, we…”
Get full text

Non-convulsive status epilepticus with negative phenomena—A SMART syndrome variant by Hametner, E, Unterberger, I, Lutterotti, A, Beer, R, Prieschl, M, Grams, A.E, Donnemiller, E, Stockhammer, G

Get full text

No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients by Lutterotti, A, Jelčić, I, Schulze, C, Schippling, S, Breiden, P, Mazzanti, B, Reinhardt, S, DiGioia, M, Repice, A, Massacesi, L, Sputtek, A, Salinas-Riester, G, Kroeger, N, Sospedra, M, Saccardi, R, Zander, A, Martin, R

“…Autologous hematopoietic stem cell transplantation (aHSCT) has been used as a therapeutic approach in multiple sclerosis (MS). However, it is still unclear if…”
Get full text

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity by Gneiss, C, Reindl, M, Lutterotti, A, Ehling, R, Egg, R, Khalil, M, Berger, T, Deisenhammer, F

“…Background: It has been reported that in some patients with MS who develop neutralizing antibodies (NAbs) against interferon beta (IFNb), antibody levels can…”
Get full text

Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis by Ehling, R, Lutterotti, A, Wanschitz, J, Khalil, M, Gneiss, C, Deisenhammer, F, Reindl, M, Berger, T

“…We investigated whether serum and cerebrospinal fluid (CSF) antibodies to the light subunit of the NF protein (NF-L), a main component of the axonal…”
Get full text

Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients by Gneiss, C, Tripp, P, Reichartseder, F, Egg, R, Ehling, R, Lutterotti, A, Khalil, M, Kuenz, B, Mayringer, I, Reindl, M, Berger, T, Deisenhammer, F

“…Interferon beta (IFNβ) is a first-line therapy for multiple sclerosis (MS). However, some patients experience a decline in efficacy with continued therapy due…”
Get full text

Interferon-β antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies by Gneiss, C., Tripp, P., Ehling, R., Khalil, M., Lutterotti, A., Egg, R., Mayringer, I., Künz, B., Berger, T., Reindl, M., Deisenhammer, F.

“…In this study, we investigated the affinity, determined by a relative affinity assay, using increasing concentrations of sodium-isothiocyanate to disrupt the…”
Get full text

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis by Jelcic, Ivan, Al Nimer, Faiez, Wang, Jian, Lentsch, Verena, Planas, Raquel, Jelcic, Ilijas, Madjovski, Aleksandar, Ruhrmann, Sabrina, Faigle, Wolfgang, Frauenknecht, Katrin, Pinilla, Clemencia, Santos, Radleigh, Hammer, Christian, Ortiz, Yaneth, Opitz, Lennart, Grönlund, Hans, Rogler, Gerhard, Boyman, Onur, Reynolds, Richard, Lutterotti, Andreas, Khademi, Mohsen, Olsson, Tomas, Piehl, Fredrik, Sospedra, Mireia, Martin, Roland

“…Multiple sclerosis is an autoimmune disease that is caused by the interplay of genetic, particularly the HLA-DR15 haplotype, and environmental risk factors…”
Get full text

Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis by Lutterotti, Andreas, Yousef, Sara, Sputtek, Andreas, Stürner, Klarissa H, Stellmann, Jan-Patrick, Breiden, Petra, Reinhardt, Stefanie, Schulze, Christian, Bester, Maxim, Heesen, Christoph, Schippling, Sven, Miller, Stephen D, Sospedra, Mireia, Martin, Roland

“…Multiple sclerosis (MS) is a devastating inflammatory disease of the brain and spinal cord that is thought to result from an autoimmune attack directed against…”
Get more information

Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients by Docampo, MJ, Batruch, M, Oldrati, P, Berenjeno-Correa, E, Hilty, M, Leventhal, G, Lutterotti, A, Martin, R, Sospedra, M

Get full text

Clinical and Immunologic Effects of Paraprobiotics in Long-COVID Patients: A Pilot Study by Docampo, María José, Batruch, Mattei, Oldrati, Pietro, Berenjeno-Correa, Ernesto, Hilty, Marc, Leventhal, Gabriel, Lutterotti, Andreas, Martin, Roland, Sospedra, Mireia

“…After the enormous health burden during the acute stages of the COVID-19 pandemic, we are now facing another important challenge, that is, long-COVID, a…”
Get full text

Mutations in the gene for toll-like receptor 4 and multiple sclerosis by Reindl, M., Lutterotti, A., Ingram, J., Schanda, K., Gassner, C., Deisenhammer, F., Berger, T., Lorenz, E.

“…: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system with heterogeneous pathological features, disease courses and…”
Get full text

Biological markers for multiple sclerosis by Lutterotti, Andreas, Berger, Thomas, Reindl, Markus

“…Multiple sclerosis (MS) is the most common disabling neurological disease in young adults and is thought to result from an autoimmune attack against…”
Get more information

B - T cell interactions activate and maintain brain-homing T cells in multiple sclerosis by Jelcic, I, Al Nimer, F, Wang, J, Lentsch, V, Planas, R, Madjovski, A, Faigle, W, Pinilla, C, Santos, R, Hammer, C, Ortiz, Y, Opitz, L, Khademi, M, Lutterotti, A, Olsson, T, Piehl, F, Sospedra, M, Martin, R

Get full text

Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary by Achtnichts, L, Chan, A, Czaplinski, A, Derfuss, T, Du Pasquier, R, Findling, O, Gobbi, C, Hoepner, R, Kamber, N, Kamm, CP, Kuhle, J, Lalive, P, Lutterotti, A, Martin, R, Müller, S, Papadopoulou, A, Pot, C, Salmen, A, Schippling, S, Zecca, C

“…More than a dozen substances are meanwhile available for the disease-modifying immunotherapy of multiple sclerosis (MS). However, for some substances, there is…”
Get full text

Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis by Kuenz, Bettina, Lutterotti, Andreas, Khalil, Michael, Ehling, Rainer, Gneiss, Claudia, Deisenhammer, Florian, Reindl, Markus, Berger, Thomas

“…Adhesion molecule mediated leukocyte migration into the central nervous system is considered to be a critical step in the pathogenesis of multiple sclerosis…”
Get full text

Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders by Reindl, Markus, Khantane, Sabrina, Ehling, Rainer, Schanda, Kathrin, Lutterotti, Andreas, Brinkhoff, Claudia, Oertle, Thomas, Schwab, Martin E., Deisenhammer, Florian, Berger, Thomas, Bandtlow, Christine E.

“…Nogo-A is a protein associated with central nervous system (CNS) myelin thought to impair regenerative responses and to suppress sprouting and plastic changes…”
Get full text

Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis by Kuenz, B, Lutterotti, A, Ehling, R, Gneiss, C, Haemmerle, M, Schocke, M, Berger, T, Reindl, M

“…Background: There is accumulating evidence from immunological, pathological and therapeutic studies that B cells are key components in the pathophysiology of…”
Get full text